Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Research by Quarter
Research — Outsourced services ex-lab supplies (FY2013–FY2018, $M) ($M)
Vertex Pharmaceuticals Research: $10.7M in Q4 2018, up 8.1% from a year earlier. No newer figure appears in the documents we track.
Where the Q4 2018 figure comes from
Calculated from reported figures: Q4 = full year (10-K) − nine months (10-Q)
Source: Form 10-K (a201810k-main.htm, filed 2019-02-13) ↗
Reported in Form 10-Q / 10-K MD&A (Research Expenses Disaggregation Table).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Research — Outsourced services ex-lab supplies (FY2013–FY2018, $M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q4 2018 | Dec 31, 2018 | 10.7 | +8.1% | Form 10-K (a201810k-main.htm, filed 2019-02-13) ↗ |
| Q3 2018 | Sep 30, 2018 | 9.20 | -9.8% | Form 10-Q (a2018q310-q.htm, filed 2018-10-25) ↗ |
| Q2 2018 | Jun 30, 2018 | 10.9 | -9.9% | Form 10-Q (a2018q210-q.htm, filed 2018-07-26) ↗ |
| Q1 2018 | Mar 31, 2018 | 7.90 | +8.2% | Form 10-Q (a2018q110-q.htm, filed 2018-04-27) ↗ |
| Q4 2017 | Dec 31, 2017 | 9.90 | – | Form 10-K (a201810k-main.htm, filed 2019-02-13) ↗ |
| Q3 2017 | Sep 30, 2017 | 10.2 | – | Form 10-Q (a2018q310-q.htm, filed 2018-10-25) ↗ |
| Q2 2017 | Jun 30, 2017 | 12.1 | – | Form 10-Q (a2018q210-q.htm, filed 2018-07-26) ↗ |
| Q1 2017 | Mar 31, 2017 | 7.30 | – | Form 10-Q (a2018q110-q.htm, filed 2018-04-27) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals Research ($M), quarterly Q1 2017–Q4 2018 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/rd-res-outsourced-pure
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.